May 12, 2025

Genomate Health Brings European Innovation and $2M in Investment to the United States

May 12, 2025

Genomate Health, a leading precision oncology company, today announced its formal entry into the U.S. market during the SelectUSA Investment Summit, the premier event for international companies scaling into the United States.

Other Media Coverage

See all

Webinar: Istvan Petak on Precision Medicine: Challenges, Journey, and Future

June 17, 2024

Read Article

Genomate Health Welcomes Digosys (Thabis) as Vietnam Exclusive Distributor

November 4, 2024

Read Article

Webinar: Matching Patients with Treatments

July 17, 2024

Read Article

Other Resources

The Genomate® Report can be used and clinically interpreted only by physicians or other qualified healthcare professionals. Genomate® is a clinical decision support software and is not intended to diagnose, treat, cure, prevent, or mitigate any condition. None of the statements contained herein have been evaluated by the U.S. Food and Drug Administration. Learn more.